日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial

在白俄罗斯开展的 CD19 CAR T 细胞疗法 BY19 用于治疗复发或难治性 B 细胞肿瘤的儿童和成人患者:I 期试验

Mikalai Katsin,Dmitri Dormeshkin,Alexandr Migas,Olga Karas,Tatsiana Shman,Yuliya Serada,Yauheniya Khalankova,Hanna Klych,Dzmitry Lutskovich,Alena Lukoika,Alexander Meleshko

Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein

编码RBD-PVXCP融合蛋白的SARS-CoV-2 DNA疫苗的设计和免疫原性

Dmitri Dormeshkin, Mikalai Katsin, Maria Stegantseva, Sergey Golenchenko, Michail Shapira, Simon Dubovik, Dzmitry Lutskovich, Anton Kavaleuski, Alexander Meleshko

Expression Pattern of Tumor-associated Antigens in Neuroblastoma: Association With Cytogenetic Features and Survival

神经母细胞瘤中肿瘤相关抗原的表达模式:与细胞遗传学特征和生存的关系

Alexander Meleshko, Lizaveta Kushniarova, Veronika Shinkevich, Taisia Mikhaleuskaya, Alena Valochnik, Inna Proleskovskaya

Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library

从新型合成纳米抗体库中分离抗逃逸的 SARS-CoV-2 中和纳米抗体

Dmitri Dormeshkin, Michail Shapira, Simon Dubovik, Anton Kavaleuski, Mikalai Katsin, Alexandr Migas, Alexander Meleshko, Sergei Semyonov

Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study

DNA-聚乙烯亚胺联合口服细菌独特型疫苗对 B 细胞非霍奇金淋巴瘤患者的安全性和免疫原性:一项初步研究

Alexander Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich, Dzmitry Lutskovich, Chuan Wang, Dmitri Dormeshkin, Natalia Savelyeva, Mikalai Katsin